BCG vaccine elicits both T-cell mediated and humoral immune responses directed against mycobacterial lipid components

Vaccine

Volumn 24, Issue 29-30, 2006, Pages 5700-5707

  Watanabe, Yoshiyuki ^a   Watari, Eiji ^a   Matsunaga, Isamu ^b   Hiromatsu, Kenji ^c   Dascher, Christopher C ^d   Kawashima, Tetsuo ^a   Norose, Yoshihiko ^a   Shimizu, Kazuo ^a   Takahashi, Hidemi ^a   Yano, Ikuya ^e   Sugita, Masahiko ^a,b  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF MIYAZAKI   (Japan)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e Kiyose   (Japan)

Author keywords

BCG; CD1; Guinea pigs; Lipid

Indexed keywords

BCG VACCINE; CD1 ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; LIPID; LIPOARABINOMANNAN; MEMBRANE LIPID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GUINEA PIG; HUMORAL IMMUNITY; IMMUNIZATION; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUBERCULOSIS; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, CD1; BCG VACCINE; FEMALE; GUINEA PIGS; HUMANS; IMMUNOGLOBULIN G; LIPIDS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MYCOBACTERIUM TUBERCULOSIS; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TUBERCULOSIS;

EID: 33745235118     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.04.049     Document Type: Article

References (47)

1. Dye C., Scheele S., Dolin P., Pathania V., and Raviglione M.C. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282 7 (1999) 677-686
2. Roche P.W., Triccas J.A., and Winter N. BCG vaccination against tuberculosis: past disappointments and future hopes. Trends Microbiol 3 10 (1995) 397-401
3. Kaufmann S.H. Immunity to intracellular bacteria. Annu Rev Immunol 11 (1993) 129-163
4. Lagranderie M.R., Balazuc A.M., Deriaud E., Leclerc C.D., and Gheorghiu M. Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains. Infect Immun 64 1 (1996) 1-9
5. Behar S.M., Dascher C.C., Grusby M.J., Wang C.R., and Brenner M.B. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J Exp Med 189 12 (1999) 1973-1980
6. Flynn J.L., Goldstein M.M., Triebold K.J., Koller B., and Bloom B.R. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 89 24 (1992) 12013-12017
7. Beckman E.M., Porcelli S.A., Morita C.T., Behar S.M., Furlong S.T., and Brenner M.B. Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. Nature 372 6507 (1994) 691-694
8. Gilleron M., Stenger S., Mazorra Z., Wittke F., Mariotti S., Bohmer G., et al. Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T cells during infection with Mycobacterium tuberculosis. J Exp Med 199 5 (2004) 649-659
9. Matsunaga I., Bhatt A., Young D.C., Cheng T.Y., Eyles S.J., Besra G.S., et al. Mycobacterium tuberculosis pks12 produces a novel polyketide presented by CD1c to T cells. J Exp Med 200 12 (2004) 1559-1569
10. Moody D.B., Reinhold B.B., Guy M.R., Beckman E.M., Frederique D.E., Furlong S.T., et al. Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science 278 5336 (1997) 283-286
11. Moody D.B., Young D.C., Cheng T.Y., Rosat J.P., Roura-Mir C., O'Connor P.B., et al. T cell activation by lipopeptide antigens. Science 303 5657 (2004) 527-531
12. Sieling P.A., Chatterjee D., Porcelli S.A., Prigozy T.I., Mazzaccaro R.J., Soriano T., et al. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 269 5221 (1995) 227-230
13. Jiao X., Lo-Man R., Guermonprez P., Fiette L., Deriaud E., Burgaud S., et al. Dendritic cells are host cells for mycobacteria in vivo that trigger innate and acquired immunity. J Immunol 168 3 (2002) 1294-1301
14. Moody D.B., Ulrichs T., Muhlecker W., Young D.C., Gurcha S.S., Grant E., et al. CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection. Nature 404 6780 (2000) 884-888
15. Ulrichs T., Moody D.B., Grant E., Kaufmann S.H., and Porcelli S.A. T-cell responses to CD1-presented lipid antigens in humans with Mycobacterium tuberculosis infection. Infect Immun 71 6 (2003) 3076-3087
16. Stenger S., Hanson D.A., Teitelbaum R., Dewan P., Niazi K.R., Froelich C.J., et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282 5386 (1998) 121-125
17. Stenger S., Mazzaccaro R.J., Uyemura K., Cho S., Barnes P.F., Rosat J.P., et al. Differential effects of cytolytic T cell subsets on intracellular infection. Science 276 5319 (1997) 1684-1687
18. Kawashima T., Norose Y., Watanabe Y., Enomoto Y., Narazaki H., Watari E., et al. Cutting edge: Major CD8 T cell response to live bacillus Calmette-Guerin is mediated by CD1 molecules. J Immunol 170 11 (2003) 5345-5348
19. Dascher C.C., Hiromatsu K., Naylor J.W., Brauer P.P., Brown K.A., Storey J.R., et al. Conservation of a CD1 multigene family in the guinea pig. J Immunol 163 10 (1999) 5478-5488
20. Hiromatsu K., Dascher C.C., LeClair K.P., Sugita M., Furlong S.T., Brenner M.B., et al. Induction of CD1-restricted immune responses in guinea pigs by immunization with mycobacterial lipid antigens. J Immunol 169 1 (2002) 330-339
21. Hiromatsu K., Dascher C.C., Sugita M., Gingrich-Baker C., Behar S.M., LeClair K.P., et al. Characterization of guinea-pig group 1 CD1 proteins. Immunology 106 2 (2002) 159-172
22. Grant E.P., Degano M., Rosat J.P., Stenger S., Modlin R.L., Wilson I.A., et al. Molecular recognition of lipid antigens by T cell receptors. J Exp Med 189 1 (1999) 195-205
23. Klunner T., Bartels T., Vordermeier M., Burger R., and Schafer H. Immune reactions of CD4- and CD8-positive T cell subpopulations in spleen and lymph nodes of guinea pigs after vaccination with Bacillus Calmette Guerin. Vaccine 19 15-16 (2001) 1968-1977
24. Dascher C.C., Hiromatsu K., Xiong X., Sugita M., Buhlmann J.E., Dodge I.L., et al. Conservation of CD1 intracellular trafficking patterns between mammalian species. J Immunol 169 12 (2002) 6951-6958
25. Hiromatsu K., Dascher C.C., Sugita M., Gingrich-Baker C., Behar S.M., LeClair K.P., et al. Characterization of guinea-pig group 1 CD1 proteins. Immunology 106 2 (2002) 159-172
26. Sugita M., Grant E.P., van Donselaar E., Hsu V.W., Rogers R.A., Peters P.J., et al. Separate pathways for antigen presentation by CD1 molecules. Immunity 11 6 (1999) 743-752
27. Glatman-Freedman A. Advances in antibody-mediated immunity against Mycobacterium tuberculosis: implications for a novel vaccine strategy. FEMS Immunol Med Microbiol 39 1 (2003) 9-16
28. Maekura R., Okuda Y., Nakagawa M., Hiraga T., Yokota S., Ito M., et al. Clinical evaluation of anti-tuberculous glycolipid immunoglobulin G antibody assay for rapid serodiagnosis of pulmonary tuberculosis. J Clin Microbiol 39 10 (2001) 3603-3608
29. Hart P.D., and Young M.R. Ammonium chloride, an inhibitor of phagosome-lysosome fusion in macrophages, concurrently induces phagosome-endosome fusion, and opens a novel pathway: studies of a pathogenic mycobacterium and a nonpathogenic yeast. J Exp Med 174 4 (1991) 881-889
30. Sturgill-Koszycki S., Schlesinger P.H., Chakraborty P., Haddix P.L., Collins H.L., Fok A.K., et al. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 263 5147 (1994) 678-681
31. Ramachandra L., Noss E., Boom W.H., and Harding C.V. Processing of Mycobacterium tuberculosis antigen 85B involves intraphagosomal formation of peptide-major histocompatibility complex II complexes and is inhibited by live bacilli that decrease phagosome maturation. J Exp Med 194 10 (2001) 1421-1432
32. Sugita M., Cao X., Watts G.F., Rogers R.A., Bonifacino J.S., and Brenner M.B. Failure of trafficking and antigen presentation by CD1 in AP-3-deficient cells. Immunity 16 5 (2002) 697-706
33. Sugita M., van Der Wel N., Rogers R.A., Peters P.J., and Brenner M.B. CD1c molecules broadly survey the endocytic system. Proc Natl Acad Sci USA 97 15 (2000) 8445-8450
34. Xu S., Cooper A., Sturgill-Koszycki S., van Heyningen T., Chatterjee D., Orme I., et al. Intracellular trafficking in Mycobacterium tuberculosis and Mycobacterium avium-infected macrophages. J Immunol 153 6 (1994) 2568-2578
35. Dascher C.C., Hiromatsu K., Xiong X., Morehouse C., Watts G., Liu G., et al. Immunization with a mycobacterial lipid vaccine improves pulmonary pathology in the guinea pig model of tuberculosis. Int Immunol 15 8 (2003) 915-925
36. Jackman R.M., Stenger S., Lee A., Moody D.B., Rogers R.A., Niazi K.R., et al. The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens. Immunity 8 3 (1998) 341-351
37. Porcelli S., Morita C.T., and Brenner M.B. CD1b restricts the response of human CD4-8- T lymphocytes to a microbial antigen. Nature 360 6404 (1992) 593-597
38. Krutzik S.R., Tan B., Li H., Ochoa M.T., Liu P.T., Sharfstein S.E., et al. TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat Med 11 6 (2005) 653-660
39. Roura-Mir C., Wang L., Cheng T.Y., Matsunaga I., Dascher C.C., Peng S.L., et al. Mycobacterium tuberculosis Regulates CD1 Antigen Presentation Pathways through TLR-2. J Immunol 175 3 (2005) 1758-1766
40. Keane J., Remold H.G., and Kornfeld H. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J Immunol 164 4 (2000) 2016-2020
41. Schaible U.E., Winau F., Sieling P.A., Fischer K., Collins H.L., Hagens K., et al. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis. Nat Med 9 8 (2003) 1039-1046
42. Teitelbaum R., Glatman-Freedman A., Chen B., Robbins J.B., Unanue E., Casadevall A., et al. A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. Proc Natl Acad Sci USA 95 26 (1998) 15688-15693
43. Chatterjee D., and Khoo K.H. Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects. Glycobiology 8 2 (1998) 113-120
44. Geijtenbeek T.B., Van Vliet S.J., Koppel E.A., Sanchez-Hernandez M., Vandenbroucke-Grauls C.M., Appelmelk B., et al. Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med 197 1 (2003) 7-17
45. Prinzis S., Chatterjee D., and Brennan P.J. Structure and antigenicity of lipoarabinomannan from Mycobacterium bovis BCG. J Gen Microbiol 139 11 (1993) 2649-2658
46. Sieling P.A., Porcelli S.A., Duong B.T., Spada F., Bloom B.R., Diamond B., et al. Human double-negative T cells in systemic lupus erythematosus provide help for IgG and are restricted by CD1c. J Immunol 165 9 (2000) 5338-5344
47. Elias D., Akuffo H., and Britton S. PPD induced in vitro interferon gamma production is not a reliable correlate of protection against Mycobacterium tuberculosis. Trans R Soc Trop Med Hyg 99 5 (2005) 363-368